<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112481">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01719666</url>
  </required_header>
  <id_info>
    <org_study_id>2010.651</org_study_id>
    <nct_id>NCT01719666</nct_id>
  </id_info>
  <brief_title>Medial Patellofemoral Ligament Reconstruction With or Without Lateral Retinaculum Release</brief_title>
  <official_title>Randomized Control Trial on Lateral Retinaculum Release in MPFL Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesis is lateral retinaculum release has no effect on treatment of
      Patellar Recurrent Dislocation with Medial Patellofemoral Ligament (MPFL) reconstruction.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Patellar tilt measurement</measure>
    <time_frame>2 years of follow up</time_frame>
    <safety_issue>No</safety_issue>
    <description>IKDC score, patellar tilt measurement on x-rays and CT-scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of complications</measure>
    <time_frame>2 years of follow up</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Episodic Patellar Dislocation</condition>
  <arm_group>
    <arm_group_label>isolated MPFL reconstruction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>MPFL reconstruction and Lateral retinaculum release</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MPFL reconstruction and lateral retinaculum release</intervention_name>
    <description>MPFL is performed with a standard technique using gracilis tendon. A tunnel is performed at the femoral part with a bioabsorbable screw fixation and 2 bundles with suture fixation at the patellar side</description>
    <arm_group_label>MPFL reconstruction and Lateral retinaculum release</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional surgery</intervention_name>
    <description>conventional surgery: MPFL reconstruction</description>
    <arm_group_label>isolated MPFL reconstruction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 18yo and 45yo

          -  indication for MPFL reconstruction

          -  unilateral or bilateral indication

        Exclusion Criteria:

          -  indication for bony procedures

          -  previous surgery for PF disorders

          -  patient refusal
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Elvire SERVIEN, MD,PhD</last_name>
    <phone>+33 4 72 26 92 51</phone>
    <email>elvire.servien@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Albert Trillat, Croix-Rousse Hospital, Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elvire SERVIEN, MD, PhD</last_name>
      <phone>+33 4 72 26 92 51</phone>
      <email>elvire.servien@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Elvire SERVIEN, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe NEYRET, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sébastien LUSTIG, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 21, 2014</lastchanged_date>
  <firstreceived_date>December 22, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MPFL</keyword>
  <keyword>patella</keyword>
  <keyword>dislocation</keyword>
  <keyword>release</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dislocations</mesh_term>
    <mesh_term>Patellar Dislocation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
